Top experts by indication / Oncology
Most active experts in Lung Cancer (NSCLC/SCLC)
2026 edition, data as of October 26, 2026
946 key opinion leaders in the directory are tagged to Lung Cancer (NSCLC/SCLC). The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 507 of the 946 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | David SpigelSarah Cannon Research Institute, TN | 30 trials |
| 2 | Alexander SpiraVirginia Cancer Specialists, VA | 19 trials |
| 3 | Alex AdjeiMN | 16 trials |
| 4 | Ramaswamy GovindanWashington University School of Medicine in St. Louis, MO | 16 trials |
| 5 | Shirish GadgeelHenry Ford Health System, MI | 15 trials |
| 6 | Nasser HannaIndiana University School of Medicine, IN | 15 trials |
| 7 | Daniel MorgenszternWashington University School of Medicine in St. Louis, MO | 15 trials |
| 8 | Afshin DowlatiUniversity Hospitals Seidman Cancer Center, OH | 14 trials |
| 9 | Thomas StinchcombeDuke University School of Medicine, NC | 14 trials |
| 10 | Pasi JanneDana-Farber Cancer Institute, MA | 13 trials |
| 11 | David GandaraUniversity of California, Davis, CA | 13 trials |
| 12 | Corey LangerUniversity of Pennsylvania, PA | 13 trials |
| 13 | Giuseppe GiacconeWeill Cornell Medicine, MD | 13 trials |
| 14 | Lecia SequistMA | 12 trials |
| 15 | Mark SocinskiAdventHealth Cancer Institute, FL | 12 trials |
| 16 | Melissa JohnsonUniversity of California, San Diego, TN | 12 trials |
| 17 | Anne TraynorUniversity of Wisconsin–Madison, WI | 12 trials |
| 18 | Charles RudinMemorial Sloan Kettering Cancer Center, NY | 12 trials |
| 19 | Chandra BelaniPA | 11 trials |
| 20 | Helena YuCA | 11 trials |
| 21 | Alberto ChiapporiMoffitt Cancer Center, FL | 11 trials |
| 22 | Nitin OhriMontefiore Einstein, PA | 11 trials |
| 23 | Martin EdelmanFox Chase Cancer Center, PA | 11 trials |
| 24 | Saiama WaqarWashington University School of Medicine in St. Louis, MO | 10 trials |
| 25 | Heather WakeleeStanford University School of Medicine, CA | 10 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 191 of the 946 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Pasi JanneDana-Farber Cancer Institute, MA | 127,638 citations |
| 2 | Julie BrahmerJohns Hopkins University School of Medicine, MD | 124,810 citations |
| 3 | Enriqueta FelipVall d'Hebron Institute of Oncology (VHIO) | 110,546 citations |
| 4 | Suresh RamalingamEmory University, GA | 106,346 citations |
| 5 | Mark KrisMemorial Sloan Kettering Cancer Center, NY | 102,631 citations |
| 6 | Ramaswamy GovindanWashington University School of Medicine in St. Louis, MO | 98,957 citations |
| 7 | Gregory RielyMemorial Sloan Kettering Cancer Center, NY | 96,674 citations |
| 8 | Roy HerbstYale School of Medicine | 94,089 citations |
| 9 | Razelle KurzrockMedical College of Wisconsin, WI | 88,610 citations |
| 10 | Charles RudinMemorial Sloan Kettering Cancer Center, NY | 88,594 citations |
| 11 | Ronald CrystalWeill Cornell Medicine, NY | 86,411 citations |
| 12 | Everett VokesUniversity of Chicago, IL | 80,021 citations |
| 13 | David SpigelSarah Cannon Research Institute, TN | 79,383 citations |
| 14 | Scott AntoniaDuke University, FL | 77,531 citations |
| 15 | Giuseppe GiacconeWeill Cornell Medicine, MD | 74,199 citations |
| 16 | Howard BurrisSarah Cannon Research Institute, TN | 72,593 citations |
| 17 | Minesh MehtaFlorida International University Herbert Wertheim College of Medicine | 71,705 citations |
| 18 | John HeymachThe University of Texas MD Anderson Cancer Center, TX | 69,203 citations |
| 19 | Nathan PennellCleveland Clinic, OH | 69,047 citations |
| 20 | Taofeek OwonikokoUniversity of Maryland School of Medicine, MD | 66,624 citations |
| 21 | Naiyer RizviSynthekine, NY | 65,566 citations |
| 22 | Ritsuko KomakiThe University of Texas MD Anderson Cancer Center, TX | 61,223 citations |
| 23 | Mitesh BoradMayo Clinic, AZ | 60,996 citations |
| 24 | Patricia GanzLos Angeles County Department of Public Health, CA | 60,891 citations |
| 25 | Edith PerezMayo Clinic, FL | 60,050 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 147 of the 946 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Ronald CrystalWeill Cornell Medicine, NY | 51 awards |
| 2 | Mary DisisWA | 23 awards |
| 3 | William CarsonThe Ohio State University, OH | 19 awards |
| 4 | Eric HauraMoffitt Cancer Center, FL | 15 awards |
| 5 | Scott KopetzThe University of Texas MD Anderson Cancer Center, TX | 13 awards |
| 6 | Evanthia GalanisMayo Clinic, MN | 13 awards |
| 7 | Aminah JatoiMayo Clinic, MN | 13 awards |
| 8 | Patricia GanzLos Angeles County Department of Public Health, CA | 12 awards |
| 9 | Bonnie KyUniversity of Pennsylvania, PA | 11 awards |
| 10 | Harriet KlugerYale School of Medicine, CT | 11 awards |
| 11 | Maximilian DiehnStanford University School of Medicine, CA | 11 awards |
| 12 | Geoffrey ShapiroDana-Farber Cancer Institute, MA | 11 awards |
| 13 | Pasi JanneDana-Farber Cancer Institute, MA | 10 awards |
| 14 | John HeymachThe University of Texas MD Anderson Cancer Center, TX | 10 awards |
| 15 | Quynh-Thu LeCA | 10 awards |
| 16 | Ramaswamy GovindanWashington University School of Medicine in St. Louis, MO | 10 awards |
| 17 | Jennifer TemelMassachusetts General Hospital, MA | 10 awards |
| 18 | Suresh RamalingamEmory University, GA | 9 awards |
| 19 | David GandaraUniversity of California, Davis, CA | 7 awards |
| 20 | Roman Perez-SolerNY | 7 awards |
| 21 | Bruce JohnsonMA | 7 awards |
| 22 | Scott AntoniaDuke University, FL | 7 awards |
| 23 | Charles RudinMemorial Sloan Kettering Cancer Center, NY | 7 awards |
| 24 | David CarboneThe Ohio State University, OH | 6 awards |
| 25 | Anthony ShieldsMI | 6 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 93 of the 946 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Erika HamiltonSarah Cannon Research Institute, TN | 364 contributions |
| 2 | Johanna BendellPfizer, TN | 310 contributions |
| 3 | James DoroshowNational Cancer Institute (NIH), MD | 296 contributions |
| 4 | Geoffrey ShapiroDana-Farber Cancer Institute, MA | 277 contributions |
| 5 | Patricia LorussoYale School of Medicine, MI | 272 contributions |
| 6 | Primo LaraUniversity of California, Davis, CA | 264 contributions |
| 7 | James GulleyNational Cancer Institute, MD | 255 contributions |
| 8 | Siqing FuThe University of Texas MD Anderson Cancer Center, TX | 241 contributions |
| 9 | Cathy EngVanderbilt University Medical Center, TN | 240 contributions |
| 10 | Lee SchwartzbergRenown Institute for Cancer, NV | 238 contributions |
| 11 | Maximilian DiehnStanford University School of Medicine, CA | 231 contributions |
| 12 | Anthony TolcherNEXT Oncology, TX | 229 contributions |
| 13 | Timothy YapThe University of Texas MD Anderson Cancer Center, TX | 221 contributions |
| 14 | Mark KrisMemorial Sloan Kettering Cancer Center, NY | 212 contributions |
| 15 | Charles RudinMemorial Sloan Kettering Cancer Center, NY | 210 contributions |
| 16 | Steven LinThe University of Texas MD Anderson Cancer Center, TX | 203 contributions |
| 17 | Jennifer TemelMassachusetts General Hospital, MA | 202 contributions |
| 18 | Afshin DowlatiUniversity Hospitals Seidman Cancer Center, OH | 201 contributions |
| 19 | Ramaswamy GovindanWashington University School of Medicine in St. Louis, MO | 197 contributions |
| 20 | Shirish GadgeelHenry Ford Health System, MI | 196 contributions |
| 21 | John HainsworthSarah Cannon Research Institute, TN | 194 contributions |
| 22 | Corey LangerUniversity of Pennsylvania, PA | 192 contributions |
| 23 | Taofeek OwonikokoUniversity of Maryland School of Medicine, MD | 188 contributions |
| 24 | Mark SocinskiAdventHealth Cancer Institute, FL | 182 contributions |
| 25 | Clifford RobinsonWashington University School of Medicine in St. Louis, MO | 178 contributions |
Emerging
53 of the 946 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Eihab AbdelfatahGA |
| Marc BallasGlaxoSmithKline, NY |
| Sharon CastellinoEmory University, GA |
| Stephane ChampiatThe University of Texas MD Anderson Cancer Center, TX |
| Arjun ChatterjeeWake Forest University Health Sciences, NC |
| Jennifer DukeVanderbilt University Medical Center, TN |
| Cathy EngVanderbilt University Medical Center, TN |
| Vincent EsguerraThe Ohio State University, OH |
| Saadia FaizThe University of Texas MD Anderson Cancer Center, TX |
| Thomas GallowayFox Chase Cancer Center, PA |
| Arpita GandhiOregon Health & Science University, OR |
| Barbara GitlitzUniversity of Southern California, CA |
| Brett HerzogIL |
| Daniel HigginsonMemorial Sloan Kettering Cancer Center, NY |
| Herbert HurwitzDuke University, NC |
| Yelena JanjigianMemorial Sloan Kettering Cancer Center, NY |
| Ryan KernMayo Clinic, MN |
| Samir KhleifGeorgetown University School of Medicine, GA |
| Merrill KiesThe University of Texas MD Anderson Cancer Center, TX |
| Ritsuko KomakiThe University of Texas MD Anderson Cancer Center, TX |
| Gottfried KonecnyUniversity of California, Los Angeles, CA |
| Heinz-Josef LenzUSC Norris Comprehensive Cancer Center, CA |
| Evan LipsonJohns Hopkins University School of Medicine, MD |
| Ariel Lopez-ChavezAllegheny Health Network, PA |
| Fabien MaldonadoVanderbilt University Medical Center, TN |
How these tables are computed
The cohort is every profile in the directory tagged to Lung Cancer (NSCLC/SCLC), from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Lung Cancer (NSCLC/SCLC) profile in the directory